Synergy Ventures
VC Fund
Menlo Park, United States
Synergy Ventures is a VC fund in Menlo Park focused on Health Care and Medical Device. Synergy has been actively involved in medical technology and venture capital since 1996. We have participated in over $800 million in equity and other financial transactions for over 70 private U.S. medical technology companies through equity investment from our Synergy Ventures funds, and, through Synergy Partners International, establishment ofstrategic alliances, investments, or acquisitions involving US medical device companies and leading Japan medical device corporations. Synergy Ventures seeks early stage investment opportunities in US medical device startups, with typical funding levels of $250K to $1M in our initial investment.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 21%
Last updated:
For AI agents: llms.txt
Industries Synergy Ventures invests in
Stages Synergy Ventures invests in
Countries Synergy Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Allan Johnston
|
|||
|
Robert Okun
|
|||
Investment Focus
Industry
- Health Care 6 (43%)
- Medical Device 6 (43%)
- Internet 3 (21%)
- Biotechnology 3 (21%)
- Manufacturing 3 (21%)
Stage
- Series B 6 (43%)
- Series A 2 (14%)
- Seed 1 (7%)
- Series D 1 (7%)
- Funding Round 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Allan Johnston
Founder and Managing Director
|
Founder and Managing Director | Total investments: 0 | Find email | |
|
Robert Okun
General Partner, Co-founder and Managing Director
|
General Partner, Co-founder and Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Averto Medical
|
Savage Medical manufactures devices for medical use, enabling patients to get solutions for gastrointestinal diseases. They offer solutions for patients suffering from gastrointestinal diseases. | $3M / Venture - Series Unknown / Nov 28, 2023 | |
Paradromics
|
Paradromics is building a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. | $20M / Seed / Jul 22, 2021 | |
Cagent Vascular
|
Cagent Vascular is a medical device company developing minimally invasive technologies to treat cardiovascular disease. | $11.9M / Series B / Jul 12, 2018 | |
Cue
|
Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep. Consumers can track 5 key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cueapp reveals the interplay of activity, food, and sleep shaping the user at a molecular level. | $45M / Series B / Jul 10, 2018 | |
|
Paradromics
|
Paradromics is building a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. | $7M / Seed / Jun 11, 2018 | |
Respirix
|
The company provides digital health software and hardware intended to offer proprietary insights into the pulmonary vasculature non-invasively and the product pipeline aims to address both at-home monitoring and critical care applications in categories such as heart failure and hemodynamics. | $1.5M / Convertible Note / Feb 01, 2016 | |
CV Ingenuity
|
CV Ingenuity, a Palo Alto, CA-based medical device company.CV Ingenuity Corp., a medical device company, develops devices for the treatment of vascular diseases to relieve vascular obstructions, inhibit restenosis, and allow natural vessel healing. It offers Drug Coated Balloon platform for the "Touch-and-Go" treatment of vasculardisease. It was incorporated in 2008 and is based in Fremont, California. As of January 10, 2013, CV Ingenuity Corp. operates as a subsidiary of Covidien plc. | $16M / Series B / Oct 04, 2011 | |
TruTouch Technologies
|
TruTouch Technologies, Inc. engages in the development, manufacture, marketing, and sale of noninvasive intoxication measurement systems for the alcohol testing market to measure a person’s alcohol concentration in the United States. The company’s products include TruTouch Guardian for daily employee alcohol screening. Its products are used invarious applications, including medical diagnostic, law enforcement, workplace and industrial safety, vehicle safety, and alcohol point-of-sale liability reduction systems. TruTouch Technologies, Inc. was founded in 2005 and is based in Albuquerque, New Mexico. | $1.3M / Dec 08, 2009 | |
Bioabsorbable Therapeutics
|
Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company usesanti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California. | $9M / Series B / May 09, 2007 | |
Fast-Chip
|
Fast-Chip, Inc. provides component level solutions for network original equipment manufacturers (OEMs). The company markets, designs, and sells high performance network coprocessors. The company’s patented technologies include packet classification algorithms, database management and arithmetic memory design. Fast-Chip, Inc. founded in 1998 and isbased in Los Altos, California. | $11M / Series B / Jul 20, 2000 | |
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Synergy Ventures invest in?
Synergy Ventures invests primarily in Health Care, Medical Device and Internet startups, most often at Series B and Series A stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Synergy Ventures?
Public channels for Synergy Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Synergy Ventures?
The team at Synergy Ventures includes Allan Johnston (Founder and Managing Director) and Robert Okun (General Partner, Co-founder and Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
